Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer2017 · 435 citations
2. 2Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer2020 · 437 citations
3. 3Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy2021 · 48 citations
4. 4Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials2022 · 246 citations
5. 5Long-term Efficacy and Safety of Enzalutamide Monotherapy in Hormone-naïve Prostate Cancer: 1- and 2-Year Open-label Follow-up Results2015 · 46 citations